Have you been diagnosed with Hepatocellular Carcinoma (HCC), also referred to as Liver Cancer? If so, you may be a good fit for a clinical trial to evaluate how 3 drugs work in combination, and which dose is the best to treat your disease. The 3 drugs are casdozokitug (casdozo-key-tug), toripalimab (tor-i-pal-i- mab) and bevacizumab (bev-uh-siz-oo-mab).

Have you been diagnosed with advanced breast, lung, colorectal, urothelial, or bladder cancer and does your doctor plan to send a sample of your tumor for genetic testing? If so, then you may be able to take part in a research study that looks at whether an expert review of your tumor genetic test results can help your doctor identify better treatment options or clinical trials that may be suitable for your cancer.

The aim of this study is to measure the efficacy (how well it works) and safety of efgartigimod compared with placebo (inactive substance) in participants with ocular myasthenia gravis (oMG). The study will also measure the long-term efficacy, safety, and tolerability of efgartigimod.

Are you right-handed? Are you between the ages 18 and 35 or 65 and 85? Are you interested in testing your memory? If so, you may be able to take part in a study on how younger and older adults learn and remember objects. You can help us learn more about how memory works in adults! Compensation provided.

Have you been diagnosed with anaplastic thyroid cancer? If so, you might be able to take part in a study to look at the effectiveness of taking cemiplimab and XL092 before and after surgery for your cancer.

Do you have a brain lesion, which could be glioblastoma (GBM), and have requested to undergo surgery for this? If so, you may be able to take part in a research study evaluating an experimental vaccine, which is created from your tumor tissue and dendritic cells isolated from your blood, can be an effective therapy when given after your standard treatment of surgery, chemotherapy, and radiation.

Did you recently have a knee osteoarthritis? If so, please participate in our study analyzing how knee joint movements are linked to cartilage strain to help treat and prevent development of knee osteoarthritis. Compensation provided.

Are you interested in the ways our social world can affect our brain and body? You may be able to participate in our research study to find out the effects of social information processing on physiology. Eligible participants will be compensated. We invite individuals from diverse backgrounds to participate, in an effort to increase representation in psychological research.

Have you been diagnosed with metastatic non-small cell lung cancer? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of pembrolizumab to the investigational drug, ivonescimab in treating this condition.

Do you have Relapsed and Refractory CLL, SLL, or Select Low-grade Lymphomas? Have you received at least 2 or more therapies that have included BTKi and venetoclax? If so, you may be able to take part in a study on a drug called ZE50-0134 to treat patients with these conditions. We will also check if various doses of this medicine are safe for treatment.